US Patent Issued to Qurient on Sept. 9 for "Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-apyridine-3-carboxamide" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,165, issued on Sept. 9, was assigned to Qurient Co. Ltd. (Gyeonggi-Do, South Korea).

"Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-apyridine-3-carboxamide" was invented by Kiyean Nam (Gyeonggi-do, South Korea), Jaeseung Kim (Seoul, South Korea), Chunwon Jung (Gyeonggi-do, South Korea) and Saeyeon Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to different forms of the compound 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide and to methods of making such forms/compo...